JBT Marel (JBTM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for May 15, 2025, to be held virtually, with voting on director elections, executive compensation, and auditor ratification.
Combination with Marel hf. completed in January 2025, creating a leading global food and beverage technology provider.
2024 marked by record revenue, adjusted EBITDA, and EPS, with strong recurring revenue and improved margins.
Board and management emphasize integrity, best practices, and stockholder value maximization.
Voting matters and shareholder proposals
Shareholders to vote on re-election of three directors for one-year terms, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as auditor.
Board recommends voting FOR all proposals.
Shareholders may submit proposals for the 2026 meeting by specified deadlines.
Board of directors and corporate governance
Board expanded to 10 members, including four from Marel; 9 are independent, 4 are women, and 1 is ethnically diverse.
Committees: Audit, Compensation and Human Resources, Governance and Sustainability—all comprised of independent directors.
Annual director elections fully effective in 2026; majority voting standard in place.
Board succession planning, diversity, and skills matrix actively managed.
Stockholder engagement program includes investor days, roadshows, and direct communications.
Latest events from JBT Marel
- Q2 2026 saw 5% revenue growth, strong orders, and improved margins, with guidance reaffirmed.JBTM
Q2 2026 - $3.9B TTM revenue, 16.2% EBITDA margin, and strong recurring revenue drive growth and resilience.JBTM
Investor presentation - All director nominees and proposals were approved, with no questions from stockholders.JBTM
AGM 2026 - Q1 2026 saw 10% revenue growth, $45M net income, and strong Protein Solutions margin gains.JBTM
Q1 2026 - Annual meeting to elect directors, approve pay, and ratify auditor, with board support.JBTM
Proxy filing - Proxy details director elections, pay-for-performance, and strong ESG focus after a transformative merger.JBTM
Proxy filing - Targeting 5–7% organic growth and >20% EBITDA margin by 2028 through digital integration.JBTM
Investor Day 2026 - 2025 saw record revenue and synergy gains, with 2026 set for further growth and margin expansion.JBTM
Q4 2025 - Merger creates a global food tech leader with strong synergies, closing by year end 2024.JBTM
Business Combination - Q1 2025 revenue hit $854M, but one-time charges drove a $173M net loss; outlook cautious.JBTM
Q1 2025